The potential of innovative trial design for efficiently evaluating repurposed drugs. (2023)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/d41573-023-00129-2
PubMed Identifier: 37537382
Publication URI: http://europepmc.org/abstract/MED/37537382
Type: Journal Article/Review
Volume: 22
Parent Publication: Nature reviews. Drug discovery
Issue: 9
ISSN: 1474-1776